Prospective analysis of 30‐day mortality following palliative chemotherapy at a tertiary cancer centre

BACKGROUND: Thirty‐day mortality after chemotherapy has been suggested as a marker of quality in oncology care. Retrospective audits worldwide have put this figure at between 8.1% and 43%, with previous retrospective Australian audits putting this figure at between 3.4% and 18%. To date, there has n...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Rep (Hoboken)
Autors principals: McCracken, James A., Dabscheck, Adrian, Coperchini, Maria, Hornung, Ilana, Jalali, Azim, Akers, Georgina, Karahalios, Amalia, Gore, Fran, Lipton, Lara
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7941511/
https://ncbi.nlm.nih.gov/pubmed/32729198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnr2.1135
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars